CyDex Pharmaceuticals Will Auction Pair of Drug Developments

Kansas City Business Journal -- CyDex Pharmaceuticals Inc. will sell a pair of uses for its Captisol technology, which helps the body’s absorption of drugs. The Lenexa-based company will auction a patent application that expands the types of beverages through which the anti-anxiety drug Zoloft can be administered as a liquid concentrate, Ralph Johnston, vice president of business development and marketing, said Monday.

MORE ON THIS TOPIC